Kay on Rheumatology

• 'Avoid Opioids to Treat Arthritis,' Says a Rheumatologist   Rheumatologic conditions can be treated effectively without the use of opioids, says Dr Jonathan Kay.
  Medscape Rheumatology, January 2018
• Withdrawing Therapy in Patients With Arthritis   Dr Jonathan Kay reviews three studies evaluating three different withdrawal strategies for patients with arthritis, from the ACR/ARHP Annual Meeting.
  Medscape Rheumatology, December 2017
• From San Diego, A Great Debate on Biosimilars   Dr Jonathan Kay provides an overview of news and views on biosimilars to be presented at ACR 2017.
  Medscape Rheumatology, November 2017
• The March of the Biosimilars Continues   Dr Jonathan Kay reviews the status of four biosimilars and stresses the importance of healthcare providers to understand their efficacy and to make them available as an additional choice for therapy.
  Medscape Rheumatology, December 2016
• Fibromyalgia: Evidence-Based Management   On the basis of new guidelines, Dr Jonathan Kay outlines his optimal approach to managing fibromyalgia.
  Medscape Rheumatology, November 2016
• From Washington, an Update on Arthritis and Arteritis   Dr Jonathan Kay discusses highlights from the 2016 American College of Rheumatology annual meeting.
  Medscape Rheumatology, November 2016
• Calling All Twentysomethings: Your DNA Could Help Cure Disease   Dr Jonathan Kay discusses the importance of biobanks in advancing basic science research and the need for more and younger people to provide samples.
  Medscape Rheumatology, June 2016
• Encouraging News for Patients on TNF Inhibitors   Dr Jonathan Kay reviews a recent analysis of Scandinavian registry data from more than 100,000 patients.
  Medscape Rheumatology, June 2016
• Biosimilar Infliximab: One Step Closer to the Pharmacy?   Dr Jonathan Kay shares his experience at the recent FDA Arthritis Advisory Committee meeting on approval of biosimilar infliximab.
  Medscape Rheumatology, February 2016
• A New, Effective Approach to Giant Cell Arteritis   Two recent studies offer encouraging results in treating giant cell arteritis.
  Medscape Rheumatology, December 2015
• An Update on Biosimilars   Biosimilars to adalimumab, etanercept, and infliximab measure up safety and efficacy-wise for rheumatology patients inadequately responsive to methotrexate.
  Medscape Rheumatology, December 2015
• New Treatment Data for Inflammatory Arthritis   Drs Jonathan Kay and Ronald van Vollenhoven discuss new arthritis treatment findings presented at this year's American College of Rheumatology annual meeting.
  Medscape Rheumatology, December 2015
• Two Valuable Treatment Advances in Rheumatoid Arthritis   Drs Jonathan Kay and Ronald van Vollenhoven discuss how biomarkers are helping guide therapy in rheumatoid arthritis.
  Medscape Rheumatology, November 2015
• An Important Consideration in Ankylosing Spondylitis   Dr Jonathan Kay talks about indication and treatment discrepancies on the ankylosing spondylitis spectrum, saying that some back pain patients end up excluded from some effective treatments.
  Medscape Rheumatology, September 2015
• RA: 20 Years Has Made a Big Difference in Treatment   With Medscape turning 20 this year, Dr Jonathan Kay looks back at the biggest advances in rheumatology over the past two decades.
  Medscape Rheumatology, September 2015
• A Caution When Diagnosing Disease   Dr Kay describes a case that illustrates the pitfalls of focusing on one set of symptoms in a patient with a very complex history.
  Medscape Rheumatology, April 2015
• Arthritic in Arizona: A Case   Dr John Kay discusses an interesting case of a patient with rheumatoid arthritis and flu-like symptoms.
  Medscape Rheumatology, April 2015
• A New Era in Pharmacotherapy   Dr Jonathan Kay discusses the ever-growing role of biosimilar therapies.
  Medscape Rheumatology, April 2015
• Treat the Syndrome, Not the Lab Test   Dr Jonathan Kay discusses an interesting case of a patient with failure to thrive, thyroiditis, lymphadenopathy, and autoimmune pancreatitis.
  Medscape Rheumatology, October 2014
• TNF Inhibitors and Breast Cancer Recurrence   Dr Jonathan Kay discusses a recent article looking at breast cancer recurrence risk in patients treated with anti-TNF agents for rheumatoid arthritis.
  Medscape Rheumatology, September 2014